{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:09Z","timestamp":1792591989398,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170775"],"award-info":[{"award-number":["82170775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370765"],"award-info":[{"award-number":["82370765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cellsig.2026.112398","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:00:00Z","timestamp":1770253200000},"page":"112398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["ADAM12-programmed ECM-CAF remodeling activates PI3K\u2013AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance"],"prefix":"10.1016","volume":"142","author":[{"given":"Tianbao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112398_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112398_bb0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10555-015-9589-6","article-title":"Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer","volume":"34","author":"Garg","year":"2015","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112398_bb0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"issue":"7693","key":"10.1016\/j.cellsig.2026.112398_bb0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112398_bb0025","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1007\/s11033-023-08689-7","article-title":"Molecular classification of urothelial bladder carcinoma","volume":"50","author":"Schwarzova","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"16","key":"10.1016\/j.cellsig.2026.112398_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165670","article-title":"Evolution of urothelial bladder cancer in the context of molecular classifications","volume":"21","author":"Minoli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112398_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0040","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.cellsig.2026.112398_bb0045","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112398_bb0050","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112398_bb0055","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41416-020-01222-8","article-title":"Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a phase 3 study (SACURA trial)","volume":"124","author":"Ueno","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.cellsig.2026.112398_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143466","article-title":"Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?","volume":"13","author":"Belhabib","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112398_bb0070","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s13346-021-01036-y","article-title":"Overcoming physical stromal barriers to cancer immunotherapy","volume":"11","author":"Chung","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0075","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112398_bb0085","article-title":"Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data","volume":"3","author":"Ma","year":"2023","journal-title":"Cell Genom."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1559-0275-8-9","article-title":"The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?","volume":"8","author":"Duffy","year":"2011","journal-title":"Clin. Proteomics"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112398_bb0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-008-0353-z","article-title":"ADAM12: a potential target for the treatment of chronic wounds","volume":"86","author":"Harsha","year":"2008","journal-title":"J. Mol. Med. (Berl)"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112398_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101226","article-title":"Regulation of fibrotic processes in the liver by ADAM proteases","volume":"8","author":"Schmidt-Arras","year":"2019","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112398_bb0105","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1158\/1078-0432.CCR-06-1066","article-title":"Molecular profiling of ADAM12 in human bladder cancer","volume":"12","author":"Frohlich","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112398_bb0110","doi-asserted-by":"crossref","first-page":"20758","DOI":"10.1074\/jbc.M110.216036","article-title":"ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis","volume":"286","author":"Roy","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112398_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081927","article-title":"A disintegrin and metalloprotease 12 promotes tumor progression by inhibiting apoptosis in human colorectal cancer","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0120","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1038\/s41598-022-10608-y","article-title":"ADAM12 is an independent predictor of poor prognosis in liver cancer","volume":"12","author":"Du","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41389-018-0096-9","article-title":"ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy","volume":"7","author":"Veenstra","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cellsig.2026.112398_bb0130","article-title":"Upregulation of ADAM12 is associated with a poor survival and immune cell infiltration in colon adenocarcinoma","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112398_bb0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41417-023-00643-w","article-title":"ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy","volume":"30","author":"Piotrowski","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0140","doi-asserted-by":"crossref","first-page":"11647","DOI":"10.1007\/s13277-014-2514-8","article-title":"EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study","volume":"35","author":"Bilgin Dogru","year":"2014","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112398_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10549-011-1431-4","article-title":"ADAM12 induces estrogen-independence in breast cancer cells","volume":"131","author":"Roy","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0150","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-05-0262","article-title":"A role for ADAM12 in breast tumor progression and stromal cell apoptosis","volume":"65","author":"Kveiborg","year":"2005","journal-title":"Cancer Res."},{"issue":"49","key":"10.1016\/j.cellsig.2026.112398_bb0155","doi-asserted-by":"crossref","first-page":"51323","DOI":"10.1074\/jbc.M409565200","article-title":"ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage","volume":"279","author":"Roy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2026.112398_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5751-13-5","article-title":"Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation","volume":"13","author":"Nyren-Erickson","year":"2014","journal-title":"J. Negat. Results Biomed."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112398_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.201209151","article-title":"Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia","volume":"201","author":"Diaz","year":"2013","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112398_bb0170","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1365-2184.2008.00557.x","article-title":"The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis","volume":"41","author":"Rocks","year":"2008","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112398_bb0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.2000.3835","article-title":"ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3","volume":"278","author":"Loechel","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12967-023-03913-1","article-title":"ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR\/ERK signaling pathway","volume":"21","author":"Xu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112398_bb0185","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1091\/mbc.e11-11-0918","article-title":"Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival","volume":"23","author":"Leyme","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115871","article-title":"ADAM12-generated basigin ectodomain binds beta1 integrin and enhances the expression of cancer-related extracellular matrix proteins","volume":"25","author":"Mygind","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112398_bb0195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"43","key":"10.1016\/j.cellsig.2026.112398_bb0200","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112398_bb0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellsig.2026.112398_bb0210","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112398_bb0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112398_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0225","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112398_bb0230","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41590-023-01642-7","article-title":"Depletion of slow-cycling PDGFRalpha(+)ADAM12(+) mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis","volume":"24","author":"Di Carlo","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2026.112398_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.668349","article-title":"CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion","volume":"11","author":"Gunaydin","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:42:12Z","timestamp":1785292932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S0898656826000483"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112398","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAM12-programmed ECM-CAF remodeling activates PI3K\u2013AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112398"}}